Literature DB >> 6759287

Successful regional immunotherapy with cell-wall skeletons of BCG and Nocardia rubra against autochthonous rat tumors.

N Nagano, K Yasumoto, K Tanaka, Y Ichinose, H Yaita, K Nomoto.   

Abstract

Autochthonous tumors induced by 3-methylcholanthrene (MCA) in the thigh of Fischer 344 rats were treated by nonspecific immunotherapy with cell-wall skeleton of BCG (BCG-CWS) or Nocardia rubra (N-CWS) after incomplete radiotherapy. When MCA-induced autochthonous tumors grew to 3 cm in diameter, they were resected and autografted to the contralateral thigh. When the autografted tumors reached 1 cm in diameter, they were exposed to a single irradiation with 2000 rad giving rise to complete shrinkage in 16.6% of the cases. The rates of complete shrinkage were increased to 36.4% and 58.3%, respectively, by combined regional immunotherapy with BCG-CWS or N-CWS. Furthermore, immunoprophylactic effects of BCG-CWS and N-CWS were also detected in this experimental system.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6759287

Source DB:  PubMed          Journal:  Gan        ISSN: 0016-450X


  3 in total

1.  Effect of Nocardia rubra cell wall skeleton and/or cyclophosphamide on leukemogenesis induced by N-ethyl-N-nitrosourea in Donryu rats.

Authors:  T Ogiu; K Furuta; C Matsuoka; A Maekawa; I Azuma
Journal:  J Cancer Res Clin Oncol       Date:  1985       Impact factor: 4.553

2.  The therapeutic effects of an immunopotentiator, PS-K, on 3-methylcholanthrene-induced autochthonous tumors in C57BL/6 mice in combination with the surgical removal of primary sites.

Authors:  M Hosokawa; T Mizukoshi; K Morikawa; Z Y Xu; H Kobayashi
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

3.  Effects of a combination of cyclophosphamide and human recombinant interleukin 2 on pulmonary metastasis after the surgical removal of a 3-methylcholanthrene-induced primary tumor in autochthonous mice.

Authors:  M Hosokawa; T Yabiku; J Ikeda; Y Sawamura; F Okada; M Komatsumoto; T Tanabe; H Kobayashi
Journal:  Jpn J Cancer Res       Date:  1988-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.